Literature DB >> 8790093

Partial retinal detachment at 3 months after threshold retinopathy of prematurity. Long-term structural and functional outcome. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity Cooperative Group.

W S Gilbert1, G E Quinn, V Dobson, J Reynolds, R J Hardy, E A Palmer.   

Abstract

OBJECTIVE: To investigate the structural and functional outcome at age 4 1/2 years of eyes that had partial retinal detachment (RD) at 3 months after the occurrence of threshold retinopathy of prematurity; these eyes were involved in the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity study.
METHODS: Of the 531 eyes in the randomized portion of the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity study, 61 had partial RD at the 3-month examination. The extent of retinal involvement was recorded, and the presence of a foveal detachment was noted. At the examination conducted at age 4 1/2 years, the fundus structure was graded into cicatricial retinopathy of prematurity outcome categories by study ophthalmologists, and the visual acuity was measured by masked examiners using the Teller Acuity Card procedure and the crowded HOTV recognition acuity test.
RESULTS: Of the 61 eyes, 7 eyes continued to have partial RD at age 4 1/2 years. Of the remaining eyes, 20 eyes had structural outcomes classified as favorable in the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity study, and 27 eyes had unfavorable structural outcomes. Data were unrecordable for 3 eyes and missing for 4 eyes. No difference in outcome was found for eyes with partial RD at 3 months that had undergone cryotherapy vs eyes that had served as controls. Only 6 eyes had a visual acuity better than 20/200. When partial RDs did not involve the fovea at 3 months, structural and functional outcomes at 4 1/2 years were better than when RDs involved the fovea. The best predictor of outcome was the extent of RD at 3 months.
CONCLUSIONS: Partial RD present 3 months after threshold retinopathy of prematurity is unstable anatomically, and the visual outcome is generally poor. Structure and function at 4 1/2 years are related to the extent of RD and the involvement of the fovea at 3 months.

Entities:  

Mesh:

Year:  1996        PMID: 8790093     DOI: 10.1001/archopht.1996.01100140287005

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

1.  Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series.

Authors:  Ramak Roohipoor; Hamed Ghasemi; Fariba Ghassemi; Reza Karkhaneh; Mohammad Riazi-Esfahani; Mehdi Nili-Ahmadabadi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-15       Impact factor: 3.117

2.  Retinopathy of prematurity: involution, factors predisposing to retinal detachment, and expected utility of preemptive surgical reintervention.

Authors:  David K Coats
Journal:  Trans Am Ophthalmol Soc       Date:  2005

3.  Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity study.

Authors:  Michael X Repka; Betty Tung; William V Good; Antonio Capone; Michael J Shapiro
Journal:  Arch Ophthalmol       Date:  2011-09

4.  Buckling surgery and supplemental intravitreal bevacizumab or photocoagulation on stage 4 retinopathy of prematurity eyes.

Authors:  Yukiko Futamura; Tetsu Asami; Norie Nonobe; Shu Kachi; Yasuki Ito; Yoshiaki Sato; Masahiro Hayakawa; Hiroko Terasaki
Journal:  Jpn J Ophthalmol       Date:  2015-08-12       Impact factor: 2.447

Review 5.  Genetic susceptibility to advanced retinopathy of prematurity (ROP).

Authors:  Barkur S Shastry
Journal:  J Biomed Sci       Date:  2010-08-25       Impact factor: 8.410

6.  Long-term results of lens-sparing vitrectomy for stages 4B and 5 retinopathy of prematurity.

Authors:  Jin Choi; Jeong Hun Kim; Seong-Joon Kim; Young Suk Yu
Journal:  Korean J Ophthalmol       Date:  2011-09-20

7.  Anti-VEGF Agents for Ocular Angiogenesis and Vascular Permeability.

Authors:  Kenichi Kimoto; Toshiaki Kubota
Journal:  J Ophthalmol       Date:  2011-11-03       Impact factor: 1.909

8.  A long-term follow-up of patients with retinopathy of prematurity treated with photocoagulation and cryotherapy.

Authors:  Sayoko Iwase; Hiroki Kaneko; Chieko Fujioka; Kota Sugimoto; Mineo Kondo; Yoshiko Takai; Shu Kachi; Hiroko Terasaki
Journal:  Nagoya J Med Sci       Date:  2014-02       Impact factor: 1.131

9.  Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.

Authors:  Frank S Ong; Jane Z Kuo; Wei-Chi Wu; Ching-Yu Cheng; Wendell-Lamar B Blackwell; Brian L Taylor; Wayne W Grody; Jerome I Rotter; Chi-Chun Lai; Tien Y Wong
Journal:  J Pers Med       Date:  2013
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.